HEMOPATIAS MALIGNAS - Instituto de Oncología Ángel H. Roffo

372 PAUTAS DE DIAGNOSTICO Y TRATAMIENTO / INSTITUTO ANGEL H. ROFFO
BIBLIOGRAFIA
66. López Guillermo A, et al. Peripheral T-cell
lymphomas: initial features, natural history, and
prognostic factors in a series of 174 patientes
diagnosed according to the REAL Classification.
Ann Oncol 1998; 9: 849-855.
67. Rizvi M.A., Evensa AM, Tallman MS et al.
T-cell non-Hodgkin lymphoma. Blood 2006 ;
107: 1255-1264.
68. Ascani S, et al. Peripheral T-cell
lymphomas. Clinico-pathologic study of 168 cases
diagnosed according to the REAL
Classification. Ann Oncol 1997; 8: 583-592.
69. Gallamini et al. Peripheral T cell
Lymphoma (u): A new prognostic model from a
retrospectiv Multicentric Clinical Study. Blood
2004; 7: 2474-2479.
70. Weidmann E et al. A phase II
immunochemotherapy study with alentuzumab,
fludarabine, cyclophosphamide, and doxorrubicin
(Campath-FCD) in peripheral T-cell lymphomas.
Blood 2006; 108: 769a.
71. Rodriguez J, et al. The results of
consolidation with autologous stem-cell
transplantation in patients with peripheral T-cell
lymphoma (PTCL) in first complete remission: the
Spanish Lymphoma and Autologous Transplantation
Group experience. Ann Oncol 2007.
72. Corradini P et al. Graft-versus-lymphoma
effect in relapsed peripheral T-cell non-Hodgkin´s
lymphomas after reduced-intensity conditioning
followed by allogeneic transplantation of
hematopoietic cells. J Clin Oncol 2004; 22:
2172-2176.